Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00368459 · ClinicalTrials.gov registry record · Phase 2
Raloxifene for Women With Alzheimer's Disease
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 42
- Enrollment target
NCT00368459: Completed Phase 2 study, sponsored by Stanford University.
NCT00368459 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00368459, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 42 participants
- Enrollment target
Study Summary
This is a multisite pilot randomized trial of raloxifene or placebo for the treatment of women with Alzheimer's disease.
Interventions
- DRUG Placebo
- DRUG raloxifene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2006-08 |
| Est. Completion | 2012-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00368459
The ClinicalTrials.gov registry entry for NCT00368459 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00368459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00368459 about?
NCT00368459 is a clinical study titled "Raloxifene for Women With Alzheimer's Disease". This is a multisite pilot randomized trial of raloxifene or placebo for the treatment of women with Alzheimer's disease.
What is the current status of trial NCT00368459?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2006-08. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00368459?
The interventions under investigation include: Placebo (DRUG), raloxifene (DRUG).
Who is sponsoring clinical trial NCT00368459?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.